Home / Articles / Bipolar vs. Monopolar TURP

Articles

Bipolar vs. Monopolar TURP

Bipolar vs. Monopolar TURP: Understanding the Gold Standard Debate in Prostate Surgery

Introduction

Transurethral resection of the prostate has been the gold standard surgical treatment for benign prostatic hyperplasia for nearly a century. By removing obstructing prostatic tissue through the urethra — no incision required — it transformed BPH surgery from a major abdominal operation into a procedure men could recover from in days. Yet even gold standards evolve.

The introduction of bipolar electrosurgery to TURP promised to solve one of its most feared complications: TUR syndrome — a potentially life-threatening dilutional hyponatremia caused by absorption of the hypotonic irrigation fluid used in traditional monopolar systems. By allowing resection in normal saline, bipolar TURP theoretically eliminated this risk entirely.

But does bipolar TURP truly outperform monopolar in the outcomes that matter most to patients — bleeding, symptom relief, urinary flow, and safety? And does it justify the higher equipment costs? The comparative evidence — including the head-to-head study published in the Iranian Urology Journal — provides clear and clinically actionable answers.

BPH and the Case for Surgical Treatment

The Burden of Symptomatic BPH

Benign prostatic hyperplasia — non-malignant enlargement of the prostate’s transition zone — is among the most prevalent conditions affecting ageing men. Driven by androgen-dependent growth of the periurethral glandular and stromal tissue, BPH produces progressive bladder outlet obstruction with resulting lower urinary tract symptoms (LUTS) in the majority of men beyond middle age.

When medications fail or absolute indications arise — acute urinary retention, recurrent infections, bladder stones, or renal impairment — surgery becomes necessary. For prostate glands in the 30–80 gram range, TURP has historically been the operation of choice.

How TURP Works

In TURP, a resectoscope — a rigid instrument containing a camera, light source, irrigation channel, and an electrosurgical loop — is inserted through the urethra. The surgeon uses the electrosurgical loop to systematically excise strips of prostatic adenoma, working from the bladder neck to the verumontanum (a fixed landmark that protects the external sphincter). Chips of tissue are flushed into the bladder and removed at the end of the procedure. The result: a widened urethral channel through the prostate, substantially reducing obstruction.

The entire procedure is performed through the native urethra — no skin incision, no abdominal entry, no anastomosis to heal.

Monopolar TURP: The Classical Approach

Electrosurgical Mechanism

In monopolar TURP, electrical current flows from the resection loop through the patient’s body to a return electrode pad placed on the skin. The electrical circuit is completed through the patient’s tissues — which requires that the irrigation fluid used to distend the bladder and maintain visualization be electrically non-conductive.

Standard monopolar irrigation fluids include:

Glycine 1.5% — most commonly used; non-conductive; hypotonic
Mannitol 3% — hypotonic, diuretic
Sorbitol 3% — hypotonic
Sterile water — maximum conductivity; rarely used alone due to hemolysis risk

The critical limitation: all monopolar irrigation fluids are hypotonic relative to plasma. When absorbed in significant quantities through opened venous sinuses in the resected prostate, they cause dilutional hyponatremia — the feared TUR syndrome.

TUR Syndrome: The Feared Complication

TUR syndrome results from systemic absorption of hypotonic irrigant — typically 1–2 liters or more — producing:

Dilutional hyponatremia: serum sodium falling from normal (~140 mEq/L) to < 120 mEq/L in severe cases
Cerebral edema: severe neurological symptoms including confusion, visual disturbances, seizures, coma
Cardiovascular effects: fluid overload, pulmonary edema, cardiac arrhythmias
Glycine toxicity (with glycine irrigation): transient blindness, encephalopathy

Historical incidence of TUR syndrome ranged from 1–10% depending on resection time, prostate size, and venous opening. Mortality from severe TUR syndrome approached 0.5–1% in older series. Even mild TUR syndrome significantly prolongs hospitalization and increases nursing requirements.

Risk factors for TUR syndrome include:

Resection time > 60 minutes
Large prostate volume (> 60 grams)
Highly vascular tissue
Low irrigation pressure differentials
Surgeon experience and technique

Bipolar TURP: The Safety Upgrade

The Bipolar Advantage: Normal Saline Irrigation

Bipolar electrosurgery reconfigures the electrical circuit entirely — current flows from the active electrode to a return electrode on the resectoscope itself, completing the circuit locally at the surgical site without traversing the patient’s body. This allows the use of isotonic normal saline (0.9% NaCl) as irrigation fluid.

The consequences of this single change are substantial:

Normal saline absorption does not cause hyponatremia — even large fluid absorption volumes do not alter serum sodium
TUR syndrome is essentially eliminated with bipolar TURP
Longer resections can be safely performed
Patients on anticoagulation are relatively safer
Cardiac pacemakers are not a contraindication (bipolar current does not interfere with pacemaker function)

Bipolar Resection Mechanism

Bipolar resection uses plasma vaporization — high-frequency current creates a plasma layer around the electrode that vaporizes and cuts tissue. This produces:

Efficient tissue cutting comparable to monopolar
Concurrent coagulation of vessels during resection
Potentially superior hemostasis at equivalent resection depths

Head-to-Head Evidence: What Comparative Studies Show

Key Outcomes in Bipolar vs. Monopolar TURP Trials

The Iranian Urology Journal comparative study, alongside the broader body of randomized and comparative evidence, consistently demonstrates the following pattern:

Outcome	Monopolar TURP	Bipolar TURP	Clinical Significance
TUR syndrome rate	1–5%	0–0.1%	Major bipolar advantage
Serum sodium change	−4 to −8 mEq/L	−0.5 to −1 mEq/L	Clinically meaningful
Blood loss / hemoglobin drop	Moderate	Equivalent or slightly less	Comparable
Transfusion rate	1–5%	1–4%	Comparable
Operative time	Baseline	5–15 min longer (typically)	Minor bipolar disadvantage
Hospital stay	2–4 days	2–4 days	Equivalent
Catheter duration	2–3 days	2–3 days	Equivalent
IPSS improvement at 3 months	12–18 points	12–18 points	Equivalent
Qmax improvement at 3 months	+10–15 mL/s	+10–15 mL/s	Equivalent
Post-void residual reduction	> 80% reduction	> 80% reduction	Equivalent
Urethral stricture rate	2–5%	2–5%	Equivalent
Retrograde ejaculation	65–80%	65–80%	Equivalent
Erectile dysfunction	5–10%	5–10%	Equivalent
Urinary incontinence	1–3%	1–3%	Equivalent

The pattern is consistent across hundreds of comparative studies and multiple meta-analyses: bipolar TURP is superior to monopolar exclusively in the prevention of TUR syndrome and associated electrolyte disturbances. All other outcomes — functional efficacy, blood loss, continence, sexual function, and re-treatment rates — are essentially equivalent.

Meta-Analytic Evidence

Multiple systematic reviews and meta-analyses — the highest level of clinical evidence — confirm this pattern:

A 2014 Cochrane systematic review of 34 randomized controlled trials including 4,000+ patients concluded:

Bipolar TURP substantially reduces TUR syndrome risk
Equivalent symptom scores and flow rates compared to monopolar at all follow-up intervals
No significant difference in major complication rates
Operative time marginally longer with bipolar in some series

A 2019 meta-analysis of 71 studies reinforced: functional outcomes identical; TUR syndrome risk eliminated.

Specific Patient Populations: Who Benefits Most from Bipolar?

High-Risk Patients for TUR Syndrome

Bipolar TURP provides its most compelling advantage over monopolar in patients at elevated TUR syndrome risk:

Large prostate glands (> 60 grams) requiring prolonged resection time
Highly vascular prostates with extensive venous opening during resection
Elderly patients with limited cardiovascular and renal reserve to manage fluid and electrolyte disturbances
Patients with cardiac conditions (heart failure, valvular disease) where fluid overload is poorly tolerated
Patients with cardiac pacemakers or implantable cardioverter-defibrillators (ICDs) — bipolar current does not interfere with device sensing
Patients on anticoagulation where bleeding and surgical time may be prolonged

The Pacemaker Consideration

This is one of the clearest absolute indications for bipolar over monopolar: monopolar current can interfere with pacemaker and ICD function, potentially causing dangerous device inhibition or inappropriate shocks. Bipolar TURP, with its locally contained current circuit, is safe in pacemaker-dependent patients. In an era of increasing cardiovascular disease and device implantation, this advantage is clinically important.

Complications Specific to Each Approach

Monopolar-Specific Complications

TUR syndrome — the defining complication; requires immediate treatment with hypertonic saline and diuretics; ICU admission in severe cases
Pacemaker interference — absolute contraindication without cardiology coordination
Electrical burns — from dispersive electrode pad malfunction (rare with modern equipment)

Bipolar-Specific Considerations

Tissue char and delayed eschar sloughing — bipolar energy may create slightly different tissue effects; some surgeons note delayed secondary bleeding at 7–14 days post-op from eschar separation, though rates are comparable to monopolar overall
Equipment cost — bipolar systems have higher capital costs than established monopolar infrastructure; in resource-limited settings this affects availability
Surgeon learning curve — bipolar resection has slightly different tactile feedback than monopolar; experienced monopolar surgeons may find an initial adjustment period

Beyond Standard TURP: The Competitive Landscape

Bipolar and monopolar TURP do not exist in a vacuum. They face competitive pressure from newer technologies that have expanded surgical options for BPH:

Technology	Mechanism	Prostate Size	Key Advantages	Limitations
Monopolar TURP	Monopolar loop resection	30–80 g	Proven; widely available; inexpensive	TUR syndrome risk; not for pacemakers
Bipolar TURP	Bipolar loop resection in saline	30–80 g	No TUR syndrome; pacemaker safe	Higher equipment cost
HoLEP	Holmium laser enucleation	Any size	Size-independent; excellent outcomes	Equipment cost; learning curve
PVP (GreenLight)	KTP laser vaporization	30–80 g	Outpatient; anticoagulation safe	Retreatment rate; no tissue for pathology
Rezūm	Steam convective water vapor	30–80 g	Office procedure; preserves ejaculation	Less durable than TURP
UroLift	Mechanical retraction of lobes	< 80 g; no median lobe	Office; preserves ejaculation/sexual function	Limited size range; retreatment
MIST procedures	Aquablation, Optilume, etc.	Variable	Novel options; emerging evidence	Less long-term data

For standard prostate sizes (30–80 grams) in men who need surgical intervention, bipolar TURP and HoLEP have become the preferred approaches at most high-volume centers with available equipment, largely displacing monopolar TURP except where resources limit access to bipolar technology.

What Patients Should Ask Before TURP

Before undergoing either form of TURP, patients should be empowered to ask:

Is my prostate size appropriate for TURP, or is simple prostatectomy/HoLEP more suitable?
Will you be performing bipolar or monopolar TURP, and why?
Do I have a pacemaker or ICD? If so, has the approach been adapted?
What is your center’s rate of blood transfusion and TUR syndrome with this procedure?
What are my expected functional outcomes — how much improvement in symptoms and flow rate?
What are the realistic risks to ejaculatory and erectile function?
If I still have urinary symptoms after TURP, what are the options?

Conclusion

The comparative evidence between bipolar and monopolar TURP delivers a clear, evidence-based verdict: bipolar technology offers a meaningful safety improvement — virtual elimination of TUR syndrome — without sacrificing any functional efficacy compared to the monopolar approach that dominated BPH surgery for decades. Symptom scores, urinary flow rates, and complication profiles are equivalent; the ability to use isotonic saline irrigation is the decisive differentiating advantage.

For most patients requiring TURP today, bipolar should be the preferred approach where equipment is available — particularly for elderly patients, those with cardiac conditions, pacemaker users, and cases requiring prolonged resection of larger glands. The Iranian Urology Journal comparative study adds to a robust body of evidence supporting this recommendation across diverse clinical settings.

Your next steps if TURP has been recommended:

Confirm whether bipolar TURP is available at your center — if not, ask whether referral to a bipolar-equipped facility is appropriate
Disclose all cardiac devices (pacemakers, ICDs) to your surgical team — this makes bipolar TURP strongly preferable
Discuss anticoagulation management with both your cardiologist and urologist well before surgery
Ask specifically about retrograde ejaculation — expected in 65–80% of patients; discuss sperm banking before surgery if fertility is a concern
Ensure realistic expectations for recovery: most men are discharged within 2–3 days with a catheter removed at 24–48 hours
Request baseline and post-operative IPSS and flow rate measurements to objectively document your improvement